Table 1.
No. of | Mean MP | Mean MP | Minimum and maximum MPs [°C] (within given percentiles)[a] | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Drug class | State | drugs | [°C] | [°C] | 0–100th | 5th–95th | 10th–90th | 15th–85th | 20th–80th | 25th–75th |
All | approved | 3164 | 162 | 160 | 25–386 | 60–268 | 80–244 | 95–231 | 108–217 | 117–205 |
discontinued | 417 | 171 | 169 | 25–371 | 70–265 | 96–251 | 110–238 | 119–226 | 129–214 | |
Oral | approved | 683 | 168 | 166 | 25–350 | 74–265 | 94–244 | 108–232 | 115–219 | 126–209 |
discontinued | 93 | 173 | 173 | 56–290 | 86–249 | 102–245 | 114–237 | 126–218 | 133–210 | |
CNS | approved | 511 | 145 | 143 | 25–316 | 53–239 | 71–218 | 83–204 | 96–191 | 105–181 |
discontinued | 80 | 173 | 168 | 50–310 | 102–282 | 116–239 | 120–226 | 127–214 | 131–210 | |
Non‐CNS | approved | 2346 | 168 | 165 | 25–386 | 66–268 | 85–249 | 100–234 | 112–222 | 122–212 |
Anticancer | approved | 211 | 179 | 181 | 32–354 | 69–283 | 96–261 | 108–234 | 118–229 | 136–219 |
Anti‐infective | approved | 428 | 182 | 181 | 37–350 | 87–280 | 104–260 | 121–245 | 131–232 | 146–220 |
Cardiovascular | approved | 400 | 154 | 152 | 25–345 | 54–263 | 71–243 | 85–223 | 100–212 | 110–196 |
[a] From the smallest to largest MPs of all drugs, min. and max. MPs (5–95th percentiles) represent the largest MP in the top 5 % low MPs (min.), and the smallest MP in the bottom 5 % high MPs (max.), respectively. The rest (10th–90th, 15th–85th, 20th–80th, and 25th–75th percentiles) could be deduced by analogy.